Human RGS16 mRNA expression levels in the CD8+ tumor-infiltrating T cells of patients with melanoma negatively correlate with the expression of genes associated with T cell stemness and are predictive of low responses to PD-1 blockade8. Here, RGS16 is linked to neoplasm.